VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $255,219 | +8.2% | 160,515 | -0.6% | 0.00% | 0.0% |
Q4 2022 | $235,800 | -65.8% | 161,507 | -0.1% | 0.00% | -66.7% |
Q3 2022 | $690,000 | +9.4% | 161,607 | -0.6% | 0.01% | +9.1% |
Q2 2022 | $631,000 | -27.3% | 162,547 | -10.9% | 0.01% | +37.5% |
Q1 2022 | $868,000 | +10.9% | 182,396 | -15.0% | 0.01% | +100.0% |
Q4 2021 | $783,000 | -35.5% | 214,566 | +41.8% | 0.00% | -33.3% |
Q3 2021 | $1,214,000 | -29.0% | 151,350 | +0.3% | 0.01% | -25.0% |
Q2 2021 | $1,711,000 | – | 150,874 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 831,625 | $7,693,000 | 1.42% |
BVF INC/IL | 3,094,174 | $28,621,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 647,556 | $5,990,000 | 0.45% |
Logos Global Management LP | 470,000 | $4,348,000 | 0.42% |
AlphaCentric Advisors LLC | 92,402 | $855,000 | 0.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 28,570 | $264,000 | 0.14% |
Opaleye Management Inc. | 103,600 | $958,000 | 0.14% |
Monashee Investment Management LLC | 84,802 | $784,000 | 0.12% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 93,900 | $869,000 | 0.08% |
Ikarian Capital, LLC | 155,599 | $1,439,000 | 0.05% |